Arabella Young, PhD

Title(s)Access Extension, Diabetes Center
SchoolSchool of Medicine
AddressLocation Required
ORCID ORCID Icon0000-0002-6845-9753 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines. Trends Immunol. 2021 04; 42(4):293-311. Kang JH, Bluestone JA, Young A. PMID: 33714688.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    2. At the Heart of Immune Checkpoint Inhibitor-Induced Immune Toxicity. Cancer Discov. 2021 03; 11(3):537-539. Young A, Bluestone JA. PMID: 33653918.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    3. Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Sci Immunol. 2020 10 02; 5(52). Lee JC, Mehdizadeh S, Smith J, Young A, Mufazalov IA, Mowery CT, Daud A, Bluestone JA. PMID: 33008914; PMCID: PMC7755924.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    4. Autoimmune Endocrinopathies: An Emerging Complication of Immune Checkpoint Inhibitors. Annu Rev Med. 2021 01 27; 72:313-330. Quandt Z, Young A, Perdigoto AL, Herold KC, Anderson MS. PMID: 32886542.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    5. Breaking β Cell Tolerance After 100 Years of Life: Intratumoral Immunotherapy-Induced Diabetes Mellitus. J Endocr Soc. 2020 Oct 01; 4(10):bvaa114. Quandt Z, Coupe C, Anderson M, Uihlein A, Young A. PMID: 32964173; PMCID: PMC7491923.
      View in: PubMed   Mentions:
    6. The Balancing Act between Cancer Immunity and Autoimmunity in Response to Immunotherapy. Cancer Immunol Res. 2018 12; 6(12):1445-1452. Young A, Quandt Z, Bluestone JA. PMID: 30510057; PMCID: PMC6281171.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimals
    7. Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors. Diabetes. 2018 08; 67(8):1471-1480. Stamatouli AM, Quandt Z, Perdigoto AL, Clark PL, Kluger H, Weiss SA, Gettinger S, Sznol M, Young A, Rushakoff R, Lee J, Bluestone JA, Anderson M, Herold KC. PMID: 29937434; PMCID: PMC6054443.
      View in: PubMed   Mentions: 144     Fields:    Translation:HumansAnimals
    8. Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity. Cell Rep. 2018 06 12; 23(11):3262-3274. Wang D, Quiros J, Mahuron K, Pai CC, Ranzani V, Young A, Silveria S, Harwin T, Abnousian A, Pagani M, Rosenblum MD, Van Gool F, Fong L, Bluestone JA, DuPage M. PMID: 29898397; PMCID: PMC6094952.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansAnimalsCells
    9. A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment. Cancer Res. 2018 02 15; 78(4):1003-1016. Young A, Ngiow SF, Gao Y, Patch AM, Barkauskas DS, Messaoudene M, Lin G, Coudert JD, Stannard KA, Zitvogel L, Degli-Esposti MA, Vivier E, Waddell N, Linden J, Huntington ND, Souza-Fonseca-Guimaraes F, Smyth MJ. PMID: 29229601.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansAnimalsCells
    10. Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease. Cancer Discov. 2016 12; 6(12):1382-1399. Liu J, Blake SJ, Yong MC, Harjunpää H, Ngiow SF, Takeda K, Young A, O'Donnell JS, Allen S, Smyth MJ, Teng MW. PMID: 27663893.
      View in: PubMed   Mentions: 215     Fields:    Translation:HumansAnimalsCells
    11. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015 Sep 15; 75(18):3800-11. Ngiow SF, Young A, Jacquelot N, Yamazaki T, Enot D, Zitvogel L, Smyth MJ. PMID: 26208901.
      View in: PubMed   Mentions: 98     Fields:    Translation:AnimalsCells
    Arabella's Networks
    Concepts (71)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-878-g44689f21 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California